We are live on ! Find out more
DARE icon

Dare Bioscience

37 hedge funds and large institutions have $8.07M invested in Dare Bioscience in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

708% more capital inflows, than outflows

Capital inflows: $2.68M | Capital outflows: $332K

200% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 4

43% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 7

9% more funds holding

Funds holding: 34 → 37 (+3)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.01% less ownership

Funds ownership: 6.87% → 6.85% (-0.01%)

Holders
37
Holders Change
+3
Holders Change %
+8.82%
% of All Funds
0.65%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
10
Increased
12
Reduced
4
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

DARE Hedge Fund Activity: Q3 2021 in Review

37 of the 5,733 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q3 2021, worth a combined $8.07M — up 26% from $6.4M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new DARE positions and 7 closed out — a net gain of 3 holders — while 12 added to existing stakes and 4 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $421K. The largest seller was Morgan Stanley, cutting an estimated $104K.

  • 37 institutional investors held Dare Bioscience (DARE) as of Q3 2021, up from 34 in Q2 2021.
  • Funds reported $8.07M of Dare Bioscience stock for Q3 2021, up 26% quarter-over-quarter.
  • 10 funds opened new Dare Bioscience positions in Q3 2021 and 7 closed out, a net change of +3 holders.
  • The largest Dare Bioscience buyer in Q3 2021 was Geode Capital Management, an estimated $421K added.
  • The largest Dare Bioscience seller in Q3 2021 was Morgan Stanley, an estimated $104K sold.

Based on aggregated 13F filings for Q3 2021.